Medicinova (MNOV) Interest & Investment Income (2017 - 2026)
Medicinova (MNOV) posted quarterly Interest & Investment Income of $301876.0 for Q4 2025, down 22.61% year-over-year from $390096.0 in Q4 2024, and down 11.43% quarter-over-quarter from $340850.0 in Q3 2025.
Medicinova (MNOV) Interest & Investment Income (2017 - 2026) Analysis & Trends
Medicinova (MNOV) has reported Interest & Investment Income for 9 consecutive years, with $301876.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Interest & Investment Income fell 22.61% year-over-year to $301876.0; the TTM figure through Dec 2025 stood at $1.3 million (down 21.97% YoY), while the FY2025 annual figure was $1.3 million, down 21.97% from the prior year.
- Interest & Investment Income declined to $301876.0 in Q4 2025 per MNOV's latest filing, from $340850.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $509046.0 in Q1 2023 and bottomed at $34338.0 in Q2 2021.
- Historically, Interest & Investment Income has averaged $288128.0 across 5 years, with a median of $338480.5 in 2025.
- Annual changes were most pronounced in 2021 — Interest & Investment Income slumped 83.58% — and 2023, when it soared 1263.31%.
- Medicinova's Interest & Investment Income stood at $36467.0 in 2021, then jumped by 1071.76% to $427304.0 in 2022, then grew by 2.1% to $436265.0 in 2023, then dropped by 10.58% to $390096.0 in 2024, then slipped by 22.61% to $301876.0 in 2025.
- Business Quant data shows MNOV's Interest & Investment Income at $301876.0 in Q4 2025, $340850.0 in Q3 2025, and $324955.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Medicinova | 68.42 Mn | 68.42 Mn | 317,759.00 | 231,931.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 231,931.00 |
| Dec 31, 2025 | 301,876.00 |
| Sep 30, 2025 | 340,850.00 |
| Jun 30, 2025 | 324,955.00 |
| Mar 31, 2025 | 336,111.00 |
| Dec 31, 2024 | 390,096.00 |
| Sep 30, 2024 | 447,847.00 |
| Jun 30, 2024 | 435,351.00 |
| Mar 31, 2024 | 397,510.00 |
| Dec 31, 2023 | 436,265.00 |
| Sep 30, 2023 | 437,934.00 |
| Jun 30, 2023 | 451,420.00 |
| Mar 31, 2023 | 509,046.00 |
| Dec 31, 2022 | 427,304.00 |
| Sep 30, 2022 | 253,755.00 |
| Jun 30, 2022 | 91,275.00 |
| Mar 31, 2022 | 37,339.00 |
| Dec 31, 2021 | 36,467.00 |
| Sep 30, 2021 | 36,153.00 |
| Jun 30, 2021 | 34,338.00 |